Get started
Work

Supplementary Figure 3 from Immune Consequences of Decreasing Tumor Vasculature with Antiangiogenic Tyrosine Kinase Inhibitors in Combination with Therapeutic Vaccines

Year: 2023
Type: supplementary-materials
Abstract: Effect of sunitinib or sorafenib in combination with rMVATwist- TRICOM vaccine on tumor compactness in the 4T1 breast cancer model.
DOI: 10.1158/2326-6066.22537010
Authors: Benedetto Farsaci, Renee N. Donahue, Michael A. Coplin, Italia Grenga, Lauren M. Lepone, Alfredo A. Molinolo, James W. Hodge
Language: English
Open Access status: gold
OpenAlex ID: W4362551166
Cites:
Cited by:
Related to: 10